Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Dynamics of trophoblast differentiation in peri-implantation-stage human embryos.

West RC, Ming H, Logsdon DM, Sun J, Rajput SK, Kile RA, Schoolcraft WB, Roberts RM, Krisher RL, Jiang Z, Yuan Y.

Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22635-22644. doi: 10.1073/pnas.1911362116. Epub 2019 Oct 21.

PMID:
31636193
2.

Survey of Occupational and Environmental Exposure Monitoring Solutions.

Horne KM, Nichols JE, Logsdon D, Phipps H, Sanders S, Wojtyniak M, McKnight LTCJ, Vigneulle R, Jackson D, Elliott J.

Mil Med. 2019 Sep 9. pii: usz219. doi: 10.1093/milmed/usz219. [Epub ahead of print]

PMID:
31498403
3.

Alterations in oocyte mitochondrial number and function are related to spindle defects and occur with maternal aging in mice and humans†.

Pasquariello R, Ermisch AF, Silva E, McCormick S, Logsdon D, Barfield JP, Schoolcraft WB, Krisher RL.

Biol Reprod. 2019 Apr 1;100(4):971-981. doi: 10.1093/biolre/ioy248.

PMID:
30476005
4.

Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.

Logsdon DP, Shah F, Carta F, Supuran CT, Kamocka M, Jacobsen MH, Sandusky GE, Kelley MR, Fishel ML.

Sci Rep. 2018 Sep 13;8(1):13759. doi: 10.1038/s41598-018-32034-9.

5.

Direct ion generation from swabs.

Jarmusch AK, Pirro V, Logsdon DL, Cooks RG.

Talanta. 2018 Jul 1;184:356-363. doi: 10.1016/j.talanta.2018.02.105. Epub 2018 Mar 12.

PMID:
29674054
6.

Invited Commentary.

Logsdon DP, Barr ML, Bowdish ME.

Ann Thorac Surg. 2018 Apr;105(4):1157-1159. doi: 10.1016/j.athoracsur.2017.12.001. Epub 2017 Dec 23. No abstract available.

PMID:
29277674
7.

Viewing the big picture on small cell lung cancer.

Logsdon DP, Kim AW.

J Thorac Dis. 2017 Oct;9(10):3613-3615. doi: 10.21037/jtd.2017.09.65. No abstract available.

8.

Sizing sub-diffraction limit electrosprayed droplets by structured illumination microscopy.

Hollerbach A, Logsdon D, Iyer K, Li A, Schaber JA, Graham Cooks R.

Analyst. 2017 Dec 18;143(1):232-240. doi: 10.1039/c7an01278k.

PMID:
29138765
9.

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.

Shah F, Logsdon D, Messmann RA, Fehrenbacher JC, Fishel ML, Kelley MR.

NPJ Precis Oncol. 2017;1. pii: 19. doi: 10.1038/s41698-017-0023-0. Epub 2017 Jun 8.

10.

Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.

Logsdon DP, Grimard M, Luo M, Shahda S, Jiang Y, Tong Y, Yu Z, Zyromski N, Schipani E, Carta F, Supuran CT, Korc M, Ivan M, Kelley MR, Fishel ML.

Mol Cancer Ther. 2016 Nov;15(11):2722-2732. Epub 2016 Aug 17.

11.

Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.

Kingsmore KM, Logsdon DK, Floyd DH, Peirce SM, Purow BW, Munson JM.

Integr Biol (Camb). 2016 Dec 5;8(12):1246-1260.

PMID:
27775742
12.

Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.

Fishel ML, Wu X, Devlin CM, Logsdon DP, Jiang Y, Luo M, He Y, Yu Z, Tong Y, Lipking KP, Maitra A, Rajeshkumar NV, Scandura G, Kelley MR, Ivan M.

J Biol Chem. 2015 Jan 30;290(5):3057-68. doi: 10.1074/jbc.M114.621995. Epub 2014 Dec 9.

13.

COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.

Xu L, Stevens J, Hilton MB, Seaman S, Conrads TP, Veenstra TD, Logsdon D, Morris H, Swing DA, Patel NL, Kalen J, Haines DC, Zudaire E, St Croix B.

Sci Transl Med. 2014 Jun 25;6(242):242ra84. doi: 10.1126/scitranslmed.3008455.

14.

Targeting DNA repair pathways for cancer treatment: what's new?

Kelley MR, Logsdon D, Fishel ML.

Future Oncol. 2014 May;10(7):1215-37. doi: 10.2217/fon.14.60. Review.

15.

Inhibition of apurinic/apyrimidinic endonuclease I's redox activity revisited.

Zhang J, Luo M, Marasco D, Logsdon D, LaFavers KA, Chen Q, Reed A, Kelley MR, Gross ML, Georgiadis MM.

Biochemistry. 2013 Apr 30;52(17):2955-66. doi: 10.1021/bi400179m. Epub 2013 Apr 18.

16.

Research from the bedside to the lab bench & back.

White RA, Silvey M, Logsdon DP.

Mo Med. 2012 May-Jun;109(3):195-8.

17.

Effects of ascorbic acid on carcinogenicity and acute toxicity of nickel subsulfide, and on tumor transplants growth in gulonolactone oxidase knock-out mice and wild-type C57BL mice.

Kasprzak KS, Diwan BA, Kaczmarek MZ, Logsdon DL, Fivash MJ, Salnikow K.

Toxicol Appl Pharmacol. 2011 Nov 15;257(1):32-7. doi: 10.1016/j.taap.2011.08.015. Epub 2011 Aug 22.

18.
19.

GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier.

Cullen M, Elzarrad MK, Seaman S, Zudaire E, Stevens J, Yang MY, Li X, Chaudhary A, Xu L, Hilton MB, Logsdon D, Hsiao E, Stein EV, Cuttitta F, Haines DC, Nagashima K, Tessarollo L, St Croix B.

Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5759-64. doi: 10.1073/pnas.1017192108. Epub 2011 Mar 18.

20.

Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model.

Heruth DP, Hawkins T, Logsdon DP, Gibson MI, Sokolovsky IV, Nsumu NN, Major SL, Fegley B, Woods GM, Lewing KB, Neville KA, Cornetta K, Peterson KR, White RA.

Genomics. 2010 Nov;96(5):303-7. doi: 10.1016/j.ygeno.2010.07.009. Epub 2010 Aug 5.

21.

Host-derived tumor endothelial marker 8 promotes the growth of melanoma.

Cullen M, Seaman S, Chaudhary A, Yang MY, Hilton MB, Logsdon D, Haines DC, Tessarollo L, St Croix B.

Cancer Res. 2009 Aug 1;69(15):6021-6. doi: 10.1158/0008-5472.CAN-09-1086. Epub 2009 Jul 21.

22.

Hematologic characterization and chromosomal localization of the novel dominantly inherited mouse hemolytic anemia, neonatal anemia (Nan).

White RA, Sokolovsky IV, Britt MI, Nsumu NN, Logsdon DP, McNulty SG, Wilmes LA, Brewer BP, Wirtz E, Joyce HR, Fegley B, Smith A, Heruth DP.

Blood Cells Mol Dis. 2009 Sep-Oct;43(2):141-8. doi: 10.1016/j.bcmd.2009.03.009. Epub 2009 May 1.

PMID:
19409822
23.

Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure.

Diwan BA, Sipowicz M, Logsdon D, Gorelick P, Anver MR, Kasprzak KS, Anderson LM.

Environ Health Perspect. 2008 Oct;116(10):1352-6. doi: 10.1289/ehp.11493. Epub 2008 Jun 13.

24.

Living vigilant lives with chronic illness: stories from older low-income minority women.

Shawler C, Logsdon D.

Health Care Women Int. 2008 Jan;29(1):76-84. doi: 10.1080/07399330701723863.

PMID:
18176881
25.

Genes that distinguish physiological and pathological angiogenesis.

Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B.

Cancer Cell. 2007 Jun;11(6):539-54.

26.

Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic.

Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, Waalkes MP.

Toxicology. 2007 Jul 1;236(1-2):7-15. Epub 2007 Mar 31.

27.

Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver.

Liu J, Xie Y, Merrick BA, Shen J, Ducharme DM, Collins J, Diwan BA, Logsdon D, Waalkes MP.

Toxicol Appl Pharmacol. 2006 Jun 15;213(3):216-23. Epub 2005 Dec 20.

PMID:
16368122
28.

Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.

Diwan BA, Riggs CW, Logsdon D, Haines DC, Olivero OA, Rice JM, Yuspa SH, Poirier MC, Anderson LM.

Toxicol Appl Pharmacol. 1999 Nov 15;161(1):82-99.

PMID:
10558926
29.

Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.

Zhang Z, Diwan BA, Anderson LM, Logsdon D, Olivero OA, Haines DC, Rice JM, Yuspa SH, Poirier MC.

Mol Carcinog. 1998 Sep;23(1):45-51.

PMID:
9766437
30.

Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.

Olivero OA, Anderson LM, Diwan BA, Haines DC, Harbaugh SW, Moskal TJ, Jones AB, Rice JM, Riggs CW, Logsdon D, Yuspa SH, Poirier MC.

J Natl Cancer Inst. 1997 Nov 5;89(21):1602-8.

PMID:
9362158
31.

Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid.

Anzano MA, Peer CW, Smith JM, Mullen LT, Shrader MW, Logsdon DL, Driver CL, Brown CC, Roberts AB, Sporn MB.

J Natl Cancer Inst. 1996 Jan 17;88(2):123-5. No abstract available.

PMID:
8537973
32.

Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.

Lucia MS, Anzano MA, Slayter MV, Anver MR, Green DM, Shrader MW, Logsdon DL, Driver CL, Brown CC, Peer CW, et al.

Cancer Res. 1995 Dec 1;55(23):5621-7.

33.

Promotion by polychlorinated biphenyls of lung and liver tumors in mice.

Anderson LM, Logsdon D, Ruskie S, Fox SD, Issaq HJ, Kovatch RM, Riggs CM.

Carcinogenesis. 1994 Oct;15(10):2245-8.

PMID:
7955061
34.

1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

Anzano MA, Smith JM, Uskoković MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL, et al.

Cancer Res. 1994 Apr 1;54(7):1653-6.

35.

Suppression of in vivo clearance of N-nitrosodimethylamine in mice by cotreatment with ethanol.

Anderson LM, Koseniauskas R, Burak ES, Logsdon DL, Carter JP, Driver CL, Gombar CT, Magee PN, Harrington GW.

Drug Metab Dispos. 1994 Jan-Feb;22(1):43-9.

PMID:
8149888
36.

Biological and environmental risk for poor developmental outcome of young children.

Rojahn J, Aman MG, Marshburn E, Moeschberger ML, King EH, Logsdon DA, Schroeder SR.

Am J Ment Retard. 1993 May;97(6):702-8.

PMID:
7686015
37.

Enhancement of tumorigenesis by N-nitrosodiethylamine, N-nitrosopyrrolidine and N6-(methylnitroso)-adenosine by ethanol.

Anderson LM, Carter JP, Driver CL, Logsdon DL, Kovatch RM, Giner-Sorolla A.

Cancer Lett. 1993 Jan 15;68(1):61-6.

PMID:
8422650
38.

Risk factors for developmental delay among infants and toddlers.

King EH, Logsdon DA, Schroeder SR.

Child Health Care. 1992 Winter;21(1):39-52. Review.

PMID:
10145594
39.

Characterization of ethanol's enhancement of tumorigenesis by N-nitrosodimethylamine in mice.

Anderson LM, Carter JP, Logsdon DL, Driver CL, Kovatch RM.

Carcinogenesis. 1992 Nov;13(11):2107-11.

PMID:
1423883
40.

A 4-week feeding study of ground red chilli (Capsicum annuum) in male B6C3F1 mice.

Jang JJ, Devor DE, Logsdon DL, Ward JM.

Food Chem Toxicol. 1992 Sep;30(9):783-7.

PMID:
1427516
41.

Conceptions of health and health behaviors of preschool children.

Logsdon DA.

J Pediatr Nurs. 1991 Dec;6(6):396-406.

PMID:
1762040
42.

Carcinogenicity study of fecapentaene-12 diacetate on skin painting in SENCAR mice.

Devor DE, Henneman JR, Keefer LK, Logsdon DL, Rice JM, Streeter AJ, Ward JM.

Cancer Lett. 1991 Jan;56(1):11-5.

PMID:
2004349
43.

Toxicokinetics of N-nitrosodimethylamine in the Syrian golden hamster.

Streeter AJ, Nims RW, Wu PP, Logsdon DL.

Arch Toxicol. 1990;64(7):562-6.

PMID:
2073129
44.

The feasibility of behavioral risk reduction in primary medical care.

Logsdon DN, Lazaro CM, Meier RV.

Am J Prev Med. 1989 Sep-Oct;5(5):249-56.

PMID:
2789846
45.

Coverage of preventive services by preferred provider organizations.

Logsdon DN, Rosen MA, Thaddeus S, Lazaro CM.

J Ambul Care Manage. 1987 May;10(2):25-35. No abstract available.

PMID:
10281772
46.

Should health insurance cover preventive services?

Logsdon DN.

Internist. 1986 Oct;27(9):11-3. No abstract available.

PMID:
10278923
47.

The insure project on preventive health services.

Rosen MA, Logsdon DN.

Stat Bull Metrop Insur Co. 1985 Jan-Mar;66(1):25-7. No abstract available.

PMID:
4060055
48.

The cost of preventive health services in primary medical care and implications for health insurance coverage.

Logsdon DN, Rosen MA.

J Ambul Care Manage. 1984 Nov;7(4):46-55. No abstract available.

PMID:
10268340
50.

Prevention in primary medical care: the INSURE Project.

Demak MM, Rosen MA, Logsdon DN.

Md State Med J. 1983 Apr;32(4):279-83. No abstract available.

PMID:
6865484

Supplemental Content

Loading ...
Support Center